Find your next paid study

Virginia Commonwealth UniversityNCT05848297

Actual pay is set by the research site.

Phase 2

A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). This study intends to ev…

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma

Bicara TherapeuticsNCT06788990

~$75 – $2,800

Actual pay is set by the research site.

MEASuRE: Metreleptin Effectiveness And Safety Registry

The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in t…

Generalised LipodystrophyPartial Lipodystrophy

Chiesi Farmaceutici S.p.A.NCT02325674

~$10 – $1,125

Actual pay is set by the research site.

Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment

This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to…

University of New MexicoNCT05489068

Actual pay is set by the research site.

3-Dimensional Optical Scanning to Assess and Monitor Malnutrition in Eating Disorders (3D-ED) Study

People with anorexia nervosa often become medically unstable because of severe malnutrition and require hospitalization for nutritional rehabilitation. Clinici…

Anorexia in AdolescenceAnorexia NervosaAnorexia Nervosa, Atypical+7 more

University of California, San FranciscoNCT07726524

~$10 – $675

Actual pay is set by the research site.

Breast CancerBreast Adenocarcinoma

Multi-institutional Prospective Pilot Study of Definitive Breast Radiation Therapy for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery

The purpose of this study is to find out if adding radiation therapy to routine medications for breast cancer helps in reducing and preventing the cancer from …

Alexander StessinNCT07122713

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Phase I/II Study of Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Background: Kaposi Sarcoma (KS) is common in people with human immunodeficiency virus (HIV) but can also occur in people who do not have HIV. KS tumors usuall…

Kaposi Sarcoma

National Cancer Institute (NCI)NCT04941274

~$150 – $2,700

Actual pay is set by the research site.

A Veteran-Centered Medically Tailored Meal Intervention to Improve Clinical and Patient Reported Outcomes in Chronic Kidney Disease (VETCKD)

This study will study if medically tailored meals can improve health and well-being among Veterans with kidney disease. Participants will be randomly assigned …

Chronic Kidney Disease

VA Office of Research and DevelopmentNCT07793591

~$10 – $675

Actual pay is set by the research site.

Peripheral Artery DiseasePeripheral Artery StenosisPeripheral Artery Calcification+1 more

The THOR IDE Study

The goal of this clinical trial is to test the Thor system in adult (≥ 18 year old) patients with de novo (new, never treated) calcified lesions in infrainguin…

Philips Clinical & Medical Affairs GlobalNCT05916950

Actual pay is set by the research site.

Phase 4

Endotype DIrected Treatment for OSA in Down Syndrome

Down syndrome is the most common genetic cause of intellectual disability. People with Down syndrome often have obstructive sleep apnea (OSA), a condition wher…

Obstructive Sleep Apnea (OSA)Down Syndrome

University of ArizonaNCT07280468

~$25 – $1,000

Actual pay is set by the research site.

Patient-Centered Video Education Intervention to Improve Rural Cancer Care Delivery in Vermont: A Feasibility Study

Care Coordination is an essential component of cancer care delivery. Many patients experience poor care coordination. In this study, we hypothesize that provis…

Cancer

University of Vermont Medical CenterNCT05723250

Actual pay is set by the research site.

Phase 3

Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment [IGNYTE-3]

This is a randomized, controlled, multicenter, open-label Phase 3 clinical study comparing VO in combination with nivolumab versus Physician's Choice treatment…

Advanced Melanoma